Stanford School of Medicine

LaneConnex
Lane Medical Library & Knowledge Management Center

Off Campus Login

a division of IRT

[searching]

Clinical Microbiology Laboratory

  • Niaz Banaei, MD, Associate Director
  • Ellen Jo Baron PhD, Director
  • Nancy Watz MT(ASCP), Reference Technologist, Antibiotic Testing
  • Diane Getsinger MT(ASCP), Reference Technologist, AFB/Mycology
  • Patricia Buchner MT(ASCP), Reference Technologist, Anaerobes

Stanford Hospital & Clinics: Antibiogram Data For Bacterial & Yeast Isolates Jan 1, 2008 - Dec 31, 2008

Antibiogram Tables

Vancomycin

Haemophilus influenzae

ICUs by Location

See also, Vancomycin & Haemophilus influenzae

Interpretation of susceptibility results

Results are reported as minimum inhibitory concentrations (MICs), the minimum amount of drug needed to inhibit growth in vitro. Interpretive criteria are based on achievable serum levels. For certain antibiotics, the amount excreted into the urine via the kidneys is above the MIC, and the agent is effective clinically in this site even though reported as "resistant". Intermediate results (I), especially for beta-lactam agents, indicate that doses higher than standard recommendations may be effective. In other cases, "I" results indicate that the organism may be susceptible or resistant but the in vitro tests are not sensitive enough to determine specifically. For this antibiogram, Intermediate results are NOT included within the "%S" category.

Stanford Hospitals and Clinics
Click here to access LaneConnex without logging in for full access to free resources. Licensed content restricted. Click here to log in for full access to all LaneConnex resources.